Suggestions

Du même auteur

CARFILZOMIB WEEKLY PLUS MELPHALAN AND PREDNISONE IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA (IFM 2012-03) / 21st Congress of the European-Hematology-Association

Archive ouverte | Leleu, X. | CCSD

International audience

Safe and prolonged survival with Long-term exposure to Pomalidomide in Relapsed/Refractory Myeloma

Archive ouverte | Fouquet, G. | CCSD

International audience. Background - The IFM2009-02 trial studied pomalidomide (4 mg daily, 21/28 versus 28/28) and dexamethasone in very advanced relapsed or refractory multiple myeloma (RRMM). We observed that 40%...

Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?

Archive ouverte | Chrétien, M. | CCSD

International audience

Chargement des enrichissements...